ARCHIVES

ODAC Recommends Approval Of Paxen; Will IVAX Break Into $1 Billion Market

This article is from The Cancer Letter archive.

Vol. 23 No. 37 | September 26, 1997

Download PDF Visit The Full Archive

Related Articles

Senate Authorizes $30 Million For Childhood Cancer Clinical Trials Research.

July 18, 2008

Arzerra Given Accelerated Approval For Leukemia

October 30, 2009

Phase III Trial of Avastin and Temozolomide Shows Reduced Risk of Cancer Progression

November 30, 2012

U. Arizona Center Finds a Way To Community Rapport

January 18, 1980

NCI Advisors: Resume Prevention Trial, Add Edometrial Sampling

May 13, 1994

House Committee Urges “Heat Shock” Cancer Center, But Can It Be Done?

July 24, 1998